HIGLOBIN Trademark Information

Trademark by CSL BEHRING AG

Pharmaceuticals derived from recombinant DNA technology for medical use in the prevention and treatment of blood disorders; intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: HIGLOBIN
Status/Status Date:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
12/29/2017
Serial Number: 85075209
Filing Date: 6/30/2010
Registration Number: 3964974
Registration Date: 5/24/2011
Goods and Services: Pharmaceuticals derived from recombinant DNA technology for medical use in the prevention and treatment of blood disorders; intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 3/8/2011
Last Applicant/Owner:
CSL BEHRING AG
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
12/29/2017
Correspondent Search:
Terence J. Linn is a correspondent of HIGLOBIN trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on